It is generally considered that the recruitment of estrogen receptor 1 (ERα) or androgen receptor (AR) to their target genes depend on the modulation of FOXA1 in breast or prostate cancer, respectively, and FOXA factors may be essential in estrogen and androgen signaling in hormone-dependent malignancies [14]–[17]. This evidence concerns the gene ESR1 and prostate cancer.